Investment Rating - The industry investment rating is "Positive" [2] Core Insights - The report highlights the accelerating global shift towards smoke-free products, with leading tobacco companies increasing their R&D investments and product offerings in the new tobacco sector. Major companies like Philip Morris International, British American Tobacco, Japan Tobacco, and Imperial Brands are projected to see revenue growth in new tobacco products of 15.0%, 2.5%, 21.1%, and 24.2% respectively for 2024, with significant future targets set for smoke-free revenue contributions [11][12][6] Summary by Sections New Tobacco Development - The report emphasizes the trend towards a smoke-free era, with leading companies adapting to changing consumer habits and increasing their focus on new tobacco products. For instance, Philip Morris aims for over two-thirds of its revenue to come from new tobacco products by 2030 [11][12] Regulatory Environment - The report notes a continued high-pressure regulatory environment overseas, with several countries implementing bans on disposable e-cigarettes and the FDA accelerating the PMTA process for new products. This regulatory landscape is expected to influence market dynamics and product iterations [3][12] Domestic Suppliers - Domestic suppliers are positioned to enhance their global market share. For example, Smoore International reported a revenue of 34.75 billion CNY in Q4 2024, with a year-on-year growth of 8.8%. The company is focusing on HNB products as a growth driver [4][15] - China Tobacco Hong Kong reported a revenue of 43.70 billion HKD in H2 2024, with a significant net profit increase of 48.4% year-on-year, indicating robust performance and strategic growth initiatives [4][17] - Yingqu Technology reported a revenue of 10.34 billion CNY in Q4 2024, with a focus on vertical integration in manufacturing, which is expected to enhance its market share as HNB penetration increases globally [5][18] Investment Recommendations - The report suggests focusing on leading tobacco companies like Smoore International and China Tobacco Hong Kong, as well as Yingqu Technology, due to their strategic positioning and growth potential in the evolving tobacco landscape [6][18]

Investment Rating - The industry investment rating is "Positive" [2] Core Insights - The report highlights the accelerating global shift towards smoke-free products, with leading tobacco companies increasing their R&D investments and product offerings in the new tobacco sector. Major companies like Philip Morris International, British American Tobacco, Japan Tobacco, and Imperial Brands are projected to see revenue growth in new tobacco products of 15.0%, 2.5%, 21.1%, and 24.2% respectively for 2024, with significant future targets for smoke-free revenue [11][12] - Compliance is emphasized as a key development theme, with ongoing regulatory pressures in overseas markets leading to a decline in disposable vape products. The report anticipates a recovery in the compliant market and an acceleration in product iteration [3][12] - Domestic suppliers are poised for growth, with companies like Smoore International and China Tobacco Hong Kong showing stable revenue performance and plans for innovation and international expansion [4][6] Summary by Sections New Tobacco Development - The report discusses the increasing penetration of new tobacco products, which is changing consumer habits. Leading companies are focusing on R&D and product innovation, with significant revenue growth expected in the coming years [11][12] - Philip Morris aims for over two-thirds of its revenue to come from new tobacco products by 2030, while British American Tobacco and Japan Tobacco have set similar ambitious targets for 2035 [11][12] Regulatory Environment - The report notes a high-pressure regulatory environment in overseas markets, with new bans on disposable vapes in Belgium, France, and the UK. The FDA in the US is also accelerating its approval processes for new products [3][12] Financial Performance of Key Players - Smoore International reported a revenue of 34.75 billion CNY in Q4 2024, with a year-on-year increase of 8.8%. The company is focusing on HNB products as a growth driver [4][15] - China Tobacco Hong Kong achieved a revenue of 43.70 billion HKD in H2 2024, with a net profit increase of 48.4%. The company is optimizing its product and channel structure for better profitability [4][17] - Yingqu Technology reported a revenue of 10.34 billion CNY in Q4 2024, with a focus on vertical integration in the manufacturing of smoking devices [5][18] Investment Recommendations - The report suggests focusing on leading companies like Smoore International and China Tobacco Hong Kong, as well as Yingqu Technology, due to their strong growth potential and strategic positioning in the evolving market [6][18]

Core Viewpoint - The company reported a decline in revenue and net profit for 2024, but showed signs of recovery in Q1 2025, particularly in non-recurring net profit, indicating potential growth in various business segments [1][7]. Financial Performance - For 2024, the company achieved revenue of 3.573 billion yuan, a year-on-year decrease of 7.45%, and a net profit of 252 million yuan, down 44.17% [1]. - In Q4 2024, revenue was 1.034 billion yuan, up 14.90% year-on-year, while net profit was 80 million yuan, down 32.01% [1]. - In Q1 2025, revenue reached 859 million yuan, a year-on-year increase of 12.45%, with net profit of 77 million yuan, up 37.81% [1]. Market Insights - The global smart controller market is projected to grow from 1.89 trillion USD in 2023 to approximately 1.98 trillion USD in 2024, with China's market expected to grow from 3.44 trillion yuan to 3.87 trillion yuan, reflecting a CAGR of 13.01% [1]. - The global new tobacco market is expected to grow by 12.7% in 2024, reaching 38.85 billion USD [2]. - The Chinese automotive electronics market reached 1.0973 trillion yuan in 2023, with an expected growth to 1.1585 trillion yuan in 2024 [2]. Product Performance - Revenue from smart control components was 1.145 billion yuan, down 13.96% year-on-year, primarily due to delays in new project capacity [3]. - Revenue from innovative consumer electronics was 1.137 billion yuan, a slight decrease of 1.55% year-on-year, with electronic cigarette sales showing stable growth [3]. - Automotive electronics revenue was 614 million yuan, up 19.43% year-on-year, benefiting from policies promoting vehicle upgrades [3]. - Health environment products saw a significant decline in revenue, down 53.14% year-on-year, due to increased market competition [3]. Financial Metrics - The gross margin for 2024 and Q1 2025 was 28.36% and 28.82%, respectively, showing a slight year-on-year decrease and increase [5]. - Operating cash flow for 2024 was 431 million yuan, down 37% year-on-year [6]. Future Outlook - The company anticipates continued improvement in performance across multiple business segments, including electronic cigarettes, automotive electronics, and health environment products, with projected revenues of 4.494 billion yuan, 5.366 billion yuan, and 6.031 billion yuan from 2025 to 2027 [7].

Investment Rating - The industry investment rating is "Positive" and maintained [6] Core Insights - Philip Morris International (PMI) reported Q1 2025 revenue of $9.3 billion, a year-on-year increase of 5.8% (10.2% adjusted) [3][4] - Revenue from smoke-free tobacco products reached $3.9 billion in Q1 2025, growing by 15.0% (20.4% adjusted), with its revenue share increasing to 42% from 39% in Q1 2024 [3][4] Summary by Sections Company Performance - PMI's heated tobacco unit (HTU) shipment volume reached 37.1 billion sticks in Q1 2025, an increase of 11.9%, with global market share for HNB products rising to 77% [9] - The number of IQOS users reached 32.2 million by the end of 2024, an increase of 3.6 million [9] Market Insights - In Japan, IQOS market share increased by 3.0 percentage points to 32.2% in Q1 2025 [9] - In Europe, IQOS products saw approximately 7.4% growth in Q1 2025, with market share in the EU rising by 1.2 percentage points to 11.4% [9] Product Growth - Nicotine pouch sales grew rapidly, with a shipment increase of 27.2% in Q1 2025, and the U.S. market saw a 53% increase in shipments [9] - PMI expects smoke-free product sales to grow by 12%-14% in 2025, with HTU products projected to grow by 10%-12% [9] Investment Opportunities - Recommended companies to watch include Yingqu Technology, Smoore International, and nicotine pouch-related companies due to the industry's growth potential [9]

[Table_Industry] 轻工制造 [Table_ReportDate] 2025 年 04 月 24 日 菲莫国际：HNB 稳健增长，口含烟延续高增 证券研究报告 行业研究 [Table_ReportType] 行业事项点评 | [Table_StockAndRank] 轻工制造 | | | --- | --- | | 投资评级 | 看好 | | 上次评级 | 看好 | 姜文镪 新消费行业首席分析师 执业编号：S1500524120004 邮箱：jiangwenqiang@cindasc.com 信达证券股份有限公司 CINDA SECURITIES CO.,LTD 北京市西城区宣武门西大街甲127号金隅大厦B 座 邮编：100031 [Table_Title] 菲莫国际：HNB 稳健增长，口含烟延续高增 [Table_ReportDate] 2025 年 04 月 24 日 本期内容提要: [Table_S [事件： Table_Summary 公司发布 ummary] ]2025 年一季报。2025Q1 收入为 93.01 亿美元（同比+5.8%， 经调整后同比+10.2%），其中新型烟草收入为 ...

菲莫国际：HNB 稳健增长，口含烟延续高增 [Table_Industry] 轻工制造 [Table_ReportDate] 2025 年 04 月 24 日 证券研究报告 行业研究 [Table_ReportType] 行业事项点评 | [Table_StockAndRank] 轻工制造 | | | --- | --- | | 投资评级 | 看好 | | 上次评级 | 看好 | 姜文镪 新消费行业首席分析师 执业编号：S1500524120004 邮箱：jiangwenqiang@cindasc.com 信达证券股份有限公司 CINDA SECURITIES CO.,LTD 北京市西城区宣武门西大街甲127号金隅大厦B 座 邮编：100031 [Table_Title] 菲莫国际：HNB 稳健增长，口含烟延续高增 [Table_ReportDate] 2025 年 04 月 24 日 本期内容提要: [Table_S [事件： Table_Summary 公司发布 ummary] ]2025 年一季报。2025Q1 收入为 93.01 亿美元（同比+5.8%， 经调整后同比+10.2%），其中新型烟草收入为 ...

Investment Rating - Industry rating is maintained as "Outperform the Market" [9] Core Insights - The report highlights the production launch of Smoore's high-end medical device project, which is expected to generate revenue of 1 billion yuan within three years [4] - The French ban on disposable e-cigarettes officially took effect on February 25, 2025, following legislative approval [5] - China's total e-cigarette export value for 2024 reached approximately 10.96 billion USD, showing a slight year-on-year decline of 1.11% [6] Summary by Sections Smoore's Medical Device Project - Smoore's skincare brand MOYAL has obtained a Class II medical device certificate and launched a non-invasive aerosol high-end medical device project, focusing on aerosol beauty equipment [4] - The project aims to achieve production in the first half of the year and expects to generate 1 billion yuan in revenue within three years [4] E-Cigarette Market Developments - The French government has implemented a ban on disposable e-cigarettes, making it the second EU country to do so after Belgium [5] - The e-cigarette export data for 2024 indicates a total export value of 10.96 billion USD, with the U.S. being the largest market, accounting for one-third of the exports [6] Company Performance - Smoore reported a revenue of 8.32 billion yuan for the first three quarters of 2024, a year-on-year increase of 4.0%, with a net profit of 1.06 billion yuan, down 11.9% [7] - The company is positioned as a global leader in aerosol technology solutions, with increasing competitive advantages amid tightening regulations [7]

Investment Rating - The report does not provide a specific investment rating for the company [1] Core Views - The company has recently achieved a Class II medical device certification for its skincare brand MOYAL, with expectations of generating a revenue of 150 million yuan in 2025 and surpassing 1 billion yuan in revenue within three years [1] - The shift towards new tobacco products is compelling leading companies to accelerate their transformation, with a projected 8.4% decline in traditional cigarette sales in the U.S. in 2024 [2] - The U.S. is expected to become a core market for heated non-combustible tobacco (HNB) products, with an estimated annual consumption of 800-900 billion pods by 2030 [3] - The company is positioned as a key supplier in the compliant market, with expectations of revenue recovery in its disposable products despite regulatory pressures [4] - Profit forecasts indicate a net profit of 1.342 billion yuan in 2024, increasing to 2.551 billion yuan by 2026, with corresponding P/E ratios of 49.8X and 30.5X respectively [5] Summary by Sections Recent Developments - The company launched a new factory for MOYAL's medical device production, aiming for significant revenue growth in the coming years [1] Market Trends - The new tobacco landscape is reshaping consumer habits, leading to a decline in traditional cigarette sales and an increased focus on HNB product development [2][3] Financial Performance - The company anticipates a recovery in revenue and profitability, with projected net profits showing a significant increase from 1.342 billion yuan in 2024 to 2.551 billion yuan in 2026 [5] Operational Insights - The company is adapting to regulatory changes and market demands, positioning itself as a core supplier in the compliant market while navigating challenges in disposable product revenues [4]